Related Experiment Videos
The histologic grading of cancer
1Department of Pathology, Georgetown University School of Medicine, Washington, DC.
Cancer
|January 1, 1995
Summary
Tumor histologic grade is a strong predictor of cancer outcome, refining the prognostic information provided by disease stage. Grading helps identify high- and low-risk patient subgroups within each stage.
Area of Science:
- Oncology
- Cancer Research
- Pathology
Background:
- Histologic tumor grade offers prognostic insights beyond disease stage.
- Poorly differentiated tumors typically exhibit more aggressive behavior than well-differentiated ones.
Purpose of the Study:
- To investigate the frequency of tumor grading and its relationship to patient outcomes.
- To analyze grading data across 15 anatomic cancer sites using Surveillance, Epidemiology, and End Results (SEER) Program data.
Main Methods:
- Analysis of 793,649 cancer cases from the SEER Program.
- Examination of grading frequency trends from 1973 to 1987.
- Correlation of tumor grade with survival rates across different stages and histologic types.
Main Results:
- Tumor grading frequency increased between 1973 and 1987, varying by site and type.
- Survival rates decreased as tumor grade advanced.
- Histologic grade identified distinct prognostic subgroups within each disease stage, refining staging accuracy.
Conclusions:
- Histologic grade is a potent prognostic indicator, particularly for urinary bladder, endometrial, and prostate cancers.
- Despite observer variation, histologic grade consistently predicts outcomes and enhances prognostic information from staging.
- Grading is crucial for identifying high- and low-risk subgroups, aiding clinical decision-making.